D'APRILE, GIANVITO
 Distribuzione geografica
Continente #
NA - Nord America 1.531
EU - Europa 209
AS - Asia 83
AF - Africa 2
SA - Sud America 1
Totale 1.826
Nazione #
US - Stati Uniti d'America 1.526
SE - Svezia 95
CN - Cina 69
IT - Italia 41
GB - Regno Unito 23
BE - Belgio 20
FR - Francia 10
IN - India 9
DE - Germania 6
AT - Austria 4
CA - Canada 3
IR - Iran 3
BG - Bulgaria 2
NG - Nigeria 2
NL - Olanda 2
SG - Singapore 2
AL - Albania 1
BS - Bahamas 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
ES - Italia 1
NO - Norvegia 1
PL - Polonia 1
PT - Portogallo 1
PY - Paraguay 1
Totale 1.826
Città #
Fairfield 254
Chandler 252
Ashburn 154
Woodbridge 129
Seattle 112
Cambridge 100
Houston 96
Wilmington 85
Nyköping 80
Ann Arbor 47
Beijing 45
Lawrence 25
Roxbury 25
Brussels 20
Ruvo Di Puglia 20
Dearborn 16
Des Moines 16
Inglewood 14
Brooklyn 12
Bari 10
Paris 9
Edinburgh 7
Pune 6
Hefei 4
London 4
Monmouth Junction 4
Vienna 4
Boardman 3
Falls Church 3
Jacksonville 3
Los Angeles 3
Martina Franca 3
San Diego 3
San Mateo 3
Amsterdam 2
Augusta 2
Cinisello Balsamo 2
Grafing 2
Hebei 2
Lagos 2
Leawood 2
Montreal 2
Mumbai 2
Nanjing 2
Prescot 2
Rome 2
Shanghai 2
Shenyang 2
Sofia 2
Stockholm 2
Washington 2
Ardabil 1
Asunción 1
Baotou 1
Bend 1
Bradford 1
Chicago 1
Forest City 1
Frankfurt am Main 1
Fuzhou 1
Guangzhou 1
Hounslow 1
Kunming 1
Lisbon 1
Madrid 1
Nanning 1
Nassau 1
New Bedfont 1
New Delhi 1
New York 1
Oslo 1
Prague 1
San José 1
Tirana 1
Toronto 1
Trani 1
Warsaw 1
Wuhan 1
Totale 1.632
Nome #
Prognostic factors in 868 advanced gastric cancer patients treated with second-line chemotherapy in the real world 116
Second-line chemotherapy in advanced biliary cancer: The present now will later be past 99
Cholangiocarcinoma: Current opinion on clinical practice diagnostic and therapeutic algorithms. A review of the literature and a long-standing experience of a referral center 96
Multicenter prospective study of angiogenesis polymorphism validation in HCC patients treated with sorafenib. An INNOVATE study protocol 92
Antiangiogenic agents after first line and sorafenib plus chemoembolization: A systematic review 87
How Serious Games for Health Enhance Empowerment Related Patient Education: The Impact of Gender 85
Metastatic gastric cancer in the last two decades: Goals achieved and future promises 82
null 80
Micro-RNA in pancreatic adenocarcinoma: Predictive/prognostic biomarkers or therapeutic targets? 80
Bone metastases in biliary cancers: A multicenter retrospective survey 79
HER-2 inhibition in gastric and colorectal cancers: Tangible achievements, novel acquisitions and future perspectives 77
Outcomes of advanced gastric cancer patients treated with at least three lines of systemic chemotherapy 76
Multimodal treatment of resectable pancreatic ductal adenocarcinoma 75
Multivariate prognostic factors analysis for second-line chemotherapy in advanced biliary tract cancer 70
Estimating survival probabilities of advanced gastric cancer patients in the second-line setting: The gastric life nomogram 70
Molecular classifications of gastric cancers: Novel insights and possible future applications 68
Second-line treatment efficacy and toxicity in older vs. non-older patients with advanced gastric cancer: A multicentre real-world study 68
The Immune Revolution in Gastrointestinal Tumours: Leading the Way or Just Following? 67
Second-line chemotherapy for advanced pancreatic cancer: Which is the best option? 66
Immunotherapy for colorectal cancer: where are we heading? 63
The distinctive molecular, pathological and clinical characteristics of BRAF-mutant colorectal tumors 57
Second-line chemotherapy in advanced biliary cancer progressed to first-line platinum-gemcitabine combination: A multicenter survey and pooled analysis with published data 54
Systemic chemotherapy for advanced rare pancreatic histotype tumors: A retrospective multicenter analysis 53
Erratum to: Outcomes of Advanced Gastric Cancer Patients Treated with at Least Three Lines of Systemic Chemotherapy (The Oncologist, (2017), 22, 12, (1463-1469), 10.1634/theoncologist.2017-0158) 51
Il prototipo: Dimensioni e Nuclei tematici per contrastare l’Abbandono scolastico (DNA) 31
Immunotherapy for gastric cancers: emerging role and future perspectives 25
Social, constructivist and informal learning processes: Together on the edge for designing digital game-based learning environments 1
Totale 1.868
Categoria #
all - tutte 8.026
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.026


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020626 4 2 3 2 141 74 60 98 104 49 73 16
2020/2021390 29 18 76 10 12 57 52 22 50 22 38 4
2021/2022227 10 4 7 16 8 16 4 22 13 8 30 89
2022/2023483 52 82 44 45 44 51 10 51 70 5 25 4
2023/2024122 6 25 8 22 13 27 1 5 1 3 2 9
2024/20255 5 0 0 0 0 0 0 0 0 0 0 0
Totale 1.868